In the study of rare diseases and precision medicine, understanding gene expression in the spatial context of tissues is essential. High-throughput sequencing and STOmics technology will enhance biological and molecular understanding of various pathologies. MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, …
MGI announces partnership with Negedia: enhance genomic sequencing technologies at the service of scientific research and precision medicine in Italy
Share.
